lytgobi
taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - αντινεοπλασματικοί παράγοντες - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.
sunitinib/sandoz caps 50.0mg/cap
sandoz pharmaceuticals d.d. (abbr. sandoz d.d.), slovenia verovskova 57, si-1000 ljubljana +386 1 580 2111 - sunitinib - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 50.0mg/cap - sunitinib 50mg - sunitinib
sunitinib/sandoz caps 12.5mg/cap
sandoz pharmaceuticals d.d. (abbr. sandoz d.d.), slovenia verovskova 57, si-1000 ljubljana +386 1 580 2111 - sunitinib - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 12.5mg/cap - sunitinib 12,5mg - sunitinib
sunitinib/sandoz caps 25.0 mg/cap
sandoz pharmaceuticals d.d. (abbr. sandoz d.d.), slovenia verovskova 57, si-1000 ljubljana +386 1 580 2111 - sunitinib - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 25.0 mg/cap - sunitinib 25mg - sunitinib
sunitinib/teva caps 25mg/cap
teva b.v., the netherlands swensweg 5, 2031 ga haarlem +310 20 2193200 - sunitinib - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 25mg/cap - sunitinib 25mg - sunitinib
sunitinib/teva caps 50mg/cap
teva b.v., the netherlands swensweg 5, 2031 ga haarlem +310 20 2193200 - sunitinib - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 50mg/cap - sunitinib 50mg - sunitinib
sunitinib/teva caps 12.5mg/cap
teva b.v., the netherlands swensweg 5, 2031 ga haarlem +310 20 2193200 - sunitinib - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 12.5mg/cap - sunitinib 12,5mg - sunitinib
sunitinib/ariti caps 37.5mg/cap
ΑΡΗΤΗ a.e. Τατοϊου 52,, 136 77 136 77, Αχαρνές, 210.8002650 - sunitinib maleate - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 37.5mg/cap - sunitinib maleate 50,119mg - sunitinib
sunitinib/ariti caps 50mg/cap
ΑΡΗΤΗ a.e. Τατοϊου 52,, 136 77 136 77, Αχαρνές, 210.8002650 - sunitinib maleate - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 50mg/cap - sunitinib maleate 66,825mg - sunitinib
sunitinib/ariti caps 25mg/cap
ΑΡΗΤΗ a.e. Τατοϊου 52,, 136 77 136 77, Αχαρνές, 210.8002650 - sunitinib maleate - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 25mg/cap - sunitinib maleate 33,413mg - sunitinib